117 related articles for article (PubMed ID: 37750590)
1. Comprehensive evaluation of serum circHAS2 as a novel diagnostic and prognostic biomarker for gastric cancer.
Ma S; Yao Y; Xu Y; Zou M; Zhou M; Abudushalamu G; Chen Y; Cai S; Zhang C; Wu G
Mol Carcinog; 2024 Jan; 63(1):94-105. PubMed ID: 37750590
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer.
Li X; Zhang Y; Li Y; Gu X; Ju S
Mol Carcinog; 2023 Oct; 62(10):1504-1517. PubMed ID: 37314123
[TBL] [Abstract][Full Text] [Related]
3. CircHAS2 promotes the proliferation, migration, and invasion of gastric cancer cells by regulating PPM1E mediated by hsa-miR-944.
Ma S; Gu X; Shen L; Chen Y; Qian C; Shen X; Ju S
Cell Death Dis; 2021 Sep; 12(10):863. PubMed ID: 34556632
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer.
Zhang Y; Gu X; Qin X; Huang Y; Ju S
Mol Med; 2022 Jun; 28(1):63. PubMed ID: 35690737
[TBL] [Abstract][Full Text] [Related]
5. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive evaluation of serum circCSPP1 as a novel diagnostic and prognostic biomarker for gastric cancer.
Shi H; Kong S
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102367. PubMed ID: 38744073
[TBL] [Abstract][Full Text] [Related]
7. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
8. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
9. Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric Cancer.
Li Y; Zhang Y; Li X; Li X; Gu X; Ju S
Int J Med Sci; 2023; 20(9):1189-1201. PubMed ID: 37575270
[No Abstract] [Full Text] [Related]
10. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
[No Abstract] [Full Text] [Related]
14. Serum circular RNA hsa_circ_0000702 as a novel biomarker for diagnosis of gastric cancer.
Yuan W; Fang R; Mao C; Chen H; Tai B; Cong H
J Clin Lab Anal; 2023 Feb; 37(3):e24842. PubMed ID: 36644969
[TBL] [Abstract][Full Text] [Related]
15. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
16. Clinical value assessment for serum hsa_tsr013526 in the diagnosis of gastric carcinoma.
Xu J; Wang Y; Li X; Zheng M; Li Y; Zhang W
Environ Toxicol; 2024 May; 39(5):2753-2767. PubMed ID: 38251933
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
18. Circulating circRNA Has_Circ_0141633 Serves as a Potential Biomarker for Gastric Cancer.
Yin G; Zheng S; Shan Y; Zhang J; Ying R; Kong W
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902223
[TBL] [Abstract][Full Text] [Related]
19. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis.
Yan J; Shao Y; Lu H; Ye Q; Ye G; Guo J
Dig Dis Sci; 2022 Aug; 67(8):3753-3762. PubMed ID: 34424459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
